the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Medical device sector expected to contribute RM20b to economy this year

PUTRAJAYA: The medical device sector is projected to contribute RM20 billion to the country’s economy this year, supported by the increase in domestic and foreign investments in the sector.

Medical Device Authority Malaysia (MDA) chief executive Dr P. Muralitharan said the sector contributed RM15.1 billion last year which included foreign and domestic investments as well as business expansion and the procurement of related equipment.

“We found that there are several foreign countries which have pledged to invest and start their operations in Malaysia such as the Czech Republic and China.

“Hence, our projection is expected to reach close to RM20 billion this year,“ he told the media after the soft launch of the Asian International Medical Technology Exhibition and Conference (Asian Medtec) by Health Minister Datuk Seri Dr Dzulkefly Ahmad here, today.

Muralitharan said Malaysia’s total market share in the medical technology and medical devices segment stood at around eight to 10 per cent of the global market worth €536 billion (€1=RM5.13) in 2021.

“We aim to increase the market share to about 10 to 15 per cent within the next few years,“ he said.

Asian Medtec plays a pivotal role in solidifying Malaysia’s position as a key hub for medical technology development in Asia, he added.

Meanwhile, Dr Dzulkefly in his speech earlier said the government has listed the medical device sector as one of the key sectors in the National Industrial Master Plan 2030 alongside other major sectors.

“Indeed, this is the first time this sector has been acknowledged at a national level as one of the economic contributors to boost the nation’s economy,“ he said, adding that the sector has created about 80,000 jobs since 2010. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings